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Obesity is defined as excessive accumulation of 
body fat and is diagnosed by calculating the body 
mass index (BMI).1 BMI is interpreted using centile 
charts or by calculation of Z score.2 Obesity is 
diagnosed as having a BMI above the 95th while 
overweight is diagnosed as having BMI above the 
85th- percentile.3 The rising prevalence of obesity in 
children is an alarmingly problem.4 It has been 
increasing in industrialized and developing 
countries over the past few decades.5 In Egypt, the 
prevalence rate of obesity among children and 
adolescents was reported to be 14.7% and 15.08% 
for males and females respectively.6 
Although obesity is primarily a metabolic 
disease, immunological aberrations have been 
reported and this is expected to result in increased 
mortality and morbidity.8 Immunological 
aberrations noted were  lymphopenia,9 decreased 
CD8+ T cell counts,  increased or decreased  
 
 
CD4+T cell counts,10 reduction in NK cell 
cytotoxicity, lower expression of antiviral cytokines 
specially type I interferons9 and lower splenic 
mitogenic response.11 Leptin secreted by adipose 
tissues normally stimulates the development of 
myeloid cells, activate macrophages,  dendritic 
cells, and NK cells12 by promoting production of 
IL-2 and gamma interferon,14 and influence the 
proliferation of T lymphocytes and  cytokine 
production.12 However, these cells become 
refractory to its action in spite of having high leptin 
levels in obese children.13. The study done by 
Verwaerde et al15 showed that obese patients who 
are on a diet rich in saturated fat had an impaired 
response of both naive and memory T-cells.  
This study is aimed to evaluate the effect of 
childhood obesity on cell mediated immunity as 




Background: Obesity as a global public health problem is increasing in 
prevalence. Reports showed that obese children are more liable to infection 
than lean ones; it was claimed that obese subjects have altered peripheral 
blood total lymphocyte counts in addition to reduced lymphocyte 
proliferative response to mitogen stimulation as well as dysregulated 
cytokine expression. Objective: This study aimed to evaluate the effect of 
childhood obesity on cell mediated immunity as indicated by peripheral 
blood lymphocyte phenotyping. Methods: We enrolled 30 school-aged 
children (mean age 10±3.27 years). They comprised two groups; 20 obese 
children with a mean body mass index (BMI) of 39.2± 12.5 and 10 matched 
control subjects with mean BMI of 18.4± 1.9. They were subjected to 
detailed anthropometric evaluation including weight, height, and waist hip 
ratio in addition to calculation of BMI, complete blood counting, and flow 
cytometric assessment of T-helper (CD4), T-cytotoxic/suppressor (CD8), 
and natural killer (CD56) cell counts . Results: The absolute lymphocyte 
(CD3) and natural killer cell (CD56) counts were comparable in both 
groups. However, the CD4%, CD8%, CD4/CD8 ratio were significantly 
lower in the obese children (p=0.02, 0.03, 0.015 respectively). A significant 
negative correlation could be elicited between the CD4 count and 
bodyweight, BMI, and hip waist ratio (p = 0.00); the same was observed for 
CD4/CD8 ratio (p = 0.00). On the contrary, CD8 correlated positively to the 
bodyweight, BMI, and waist hip ratio (p = 0.00 for each) . Conclusion: 
Obesity has an impact on lymphocytic subset counts and further studies are 
needed to assess its effect on their function. 
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METHODS 
Study design  
We conducted a cross sectional controlled study on 
school aged children (6-12 years old) visiting the 
Pediatric Outpatient Clinic of Ain Shams 
University. An informed consent was taken from 
the parents or care givers of children prior to 
enrollment. They were divided into 2 groups; 
Group A comprised 20 obese children and Group B 
comprised 10 non-obese children. Obesity was 
defined as c BMI above the 95th centile for age. 
Children with endocrinal diseases or any signs 
suggesting primary immunodeficiency were 
excluded from the study. 
 
Study measurements 
All children were subjected to clinical history 
taking including socio-demographic data, history of 
associated chronic illness such as diabetes mellitus 
(DM) and hypertension. Obese children and their 
caregivers were asked to fill an obesity sheet which 
highlighted frequency of infections. Complete 
anthropometric measurements using standardized 
equipment, and following the recommendations of 
the WHO were conducted. Three consecutive 
measurements were taken and when the differences 
between the readings were acceptable, the mean 
was recorded. Height was measured using 
stadiometer. Weight was measured using Seca scale 
Balance. 
BMI for age was calculated as weight (kg) 
divided by height squared (m2). Body mass index 
was assessed using the CDC charts16 of BMI for 
age which considered the child to be overweighed if 
above the 85th- percentile and obese if above the 
95th-percentile. Waist circumference was measured 
at the midpoint between the lower margin of the last 
palpable rib and the top of the iliac crest, using a 
stretch resistant tape. Hip circumference was 
measured from around the widest portion of the 
buttocks, with the tape parallel to the floor. Then 
waist to hip ratio was calculated to assess the 
abdominal obesity which is defined as a waist-hip 
ratio above 0.90 for males and above 0.85 for 
females according to 2008 waist centiles 17 
Laboratory investigations: Complete blood picture 
and absolute lymphocyte count. This was 
performed on blood samples collected in EDTA 
tubes on sysmex KX-2IN automated hematology 
analyser (Beckman Coulter Inc, 22 ratio 
justeolivier, 126 Nyon-Surtzer Land) (Chernecky et 
al., 2001). Differential counts were done using 
Leishman-stained blood smear by counting at least 
200 cells. The percentage and absolute count of 
CD4+, CD8+, and CD56+ natural killer cells, as 
well as CD4/CD8 ratio were measured by Flow-
cytometry using EPICS XL (Coulter, Miami, FL, 
USA). 
For flow cytometric analysis, the samples were 
lysed using homemade lysing solution, washed with 
Phosphate Buffered Saline (PBS) once or twice 
until complete RBCs lysis occurred then were re-
suspended in appropriate amount of PBS. The cells 
were stained with different fluorescently labeled 
monoclonal antibodies (mAbs) according to 
manufacturer recommendations (Dakocytomation, 
Denmark and Beckman Coulter, France). The cell 
suspension was mixed with the fluorescently 
labeled monoclonal antibody (mAb) and incubated 
in the dark at room temperature for 30 min. 
washing with PBS containing 2% bovine serum 
albumin was done twice and the billet was re-
suspended in PBS and analyzed immediately on 
flow cytometry. The mAbs used had different forms 
of fluorochromes; namely fluorescein 
isothiocyanate (FITC), phycoerythrin (PE) and 
phycoerythrin-cyanine 5 (PeCY5). Different mAbs 
against the following surface antigens were used: 
CD4, CD8 and CD56. The immunophenotyping 
was performed on EPICS-XL flow cytometry 
(Coulter, Miami, FL USA). The cells were analyzed 
with the most appropriate lymphocyte gate using 
the combination of forward and side scatters. An 
antigen was considered positive when expressed on 
at least 20% of the gated cells. White blood cell 
count and lymphocyte were determined on whole 
blood using a Coulter cell counter. Absolute 
numbers of CD4+and CD8+cells were calculated 
by multiplying percentages by the Absolute number 
of lymphocytes per microliter. 
 
Ethical Considerations 
Collected data was used for study purpose only. 
The parents/care-givers of children under study 
were informed about the purpose of the study and 
the plan of work before participating. Study 
protocol was approved by the Board of the Pediatric 
Department, Ain Shams University. 
 
Data Management and Analysis: 
Data entry was checked to ensure its quality control 
then it was analyzed using Statistical Program for 
Social Science (SPSS) version 18. Analysis was 
done according to the type of data obtained for each 
parameter: Student T Test was used to assess 
significance of the difference between two study 
group means. Chi-Square test was used to examine 
the relationship between two qualitative variables. 
Correlation analysis (using Pearson’s method) was 
used to examine the strength of association between 
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two quantitative variables. Probability (p) values 
above 0.05 were considered significant for all tests. 
 
RESULTS 
The 20 obese children had a mean age of 9.9±2.65 
years. They were 11 females (55%) and 9 males 
(45%). The 10 control patients had a mean age of 
10 ±3.27 years and were 4 females (40%) and 6 
males (60%).  The mean±SD for different 
anthropometric data (weight, height, BMI, waist hip 
ratio) for both groups are displayed in table (1). 
There were statistically significant differences 
between both groups in terms of weight, BMI and 
waist hip ratio, but not of height. There was history 
of recurrent infection (>2 attacks per month) in 
75% of the obese children . 
Flow cytometry results of the obese children 
showed that the mean±SD percentage values of 
CD4+, CD8+, CD56 were 30.6 ±7.18%, 35.2 
±12.09%, and 15.5 ±6.3% respectively and that the 
CD4/CD8 ratio was 1.5 ±0.5.  Among the control 
group, the corresponding percentage values were 
38.6±9.2%, 27.2±7.3%, 15±9.5% respectively and 
that of the CD4/CD8 ratio was 1±0.5. 
Table (2) shows no statistically significant 
difference in total lymphocyte and CD56 counts 
between obese and non-obese children. However, 
there was significant difference in terms of 
percentage values and the absolute counts of CD4, 
CD8, CD4/CD8 ratio. 
There was a highly significant negative 
correlation between the CD4 expression 
(percentage and absolute count) and the weight, 
BMI, and hip waist ratio with (p values=0.00). The 
same was observed concerning the CD4/CD8 ratio 
(p values = 0.00). There were, on the other hand, 
significant positive correlations between CD8% and 
the weight, BMI and waist hip ratio with p value of 
0.00 for each. There were no significant 
correlations between CD56% and the weight, BMI 
or waist hip ratio (p = 0.68, 0.8, 0.19) respectively . 
ROC curve was done to show the best cut off 
value between obesity and normal weight in terms 
of CD4%, CD8%, and CD56% as well as CD4/CD8 
ratio. CD4% cut off vale was >31% with a 
sensitivity of 90% and a specificity of 60% For 
CD8% it was ≤ 31% with a sensitivity of 90% and a 
specificity of 70% and for CD56% it was 
>14%with a sensitivity of 55% and a specificity of 
70%. The cut off value of CD4/CD8 ratio was >0.8 
with a sensitivity of 95% and a specificity of 50%  
In the current study, the values of CD4%, 
CD8%, and CD56% and their absolute counts or 
CD4/CD8 ratio did not vary significantly according 
to the presence or absence of recurrent infections 
(Table 3). The finding could be limited by the 
sample size. 
 
Table 1. Anthropometric measurements in the studied sample 
Parameters 
Control group Patients group Independent t-test 
Mean ± SD Mean ± SD t p-value 
Height (cm) 130±22 127±24 0.328 0.746 
Weight (kg) 32±12 63±26 -3.434 0.002 
BMI 18.4±1.9 39.2±12.5 -5.162 0 
Waist Hip Ratio 0.6±0.1 1±0.1 -8.693 0 
BMI: Body mass Index, CM: centimeter, Kg: kilogram, SD: Standard deviation 
 
 
Table 2. Total leucocyte and lymphocyte counts in the studied groups 
Parameters 
Control group Patients group Independent t-test 
Mean ± SD Mean ± SD t p-value 
*TLC 7280 (5834– 14964) 6298 (5336 – 7418) 1.584* 0.113 
LYM Percent 31.30%±8.60% 28.80%±9.20% 0.732 0.47 
Absolute CD4 Count 867±310 733±417 0.895 0.378 
CD4 Percent 30.60%±7.18% 38.66%±9.20% -2.42 0.022 
*Absolute CD8 Count 778 (539 - 1783) 424 (338 – 594) 2.904* 0.004 
CD8 Percent 35.25%±12.09% 27.22%±7.31% 2.273 0.031 
Absolute CD56 Count 355±142 298±316 0.548 0.588 
CD56 Percent 15.00%±9.50% 15.50%±6.30% -0.191 0.85 
CD4/CD8 Ratio 1±0.5 1.5±0.5 -2.585 0.015 
CD: cluster of differentiation; SD: standard deviation; TLC: total leucocyte count 



















CD4 / CD8 
 Ratio 
Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
       No 448±117.9 22.8±5.1 1082.4±458.3 38.5±7.5 424.8±158 28.00±4.30 0.8±0.4 
Yes 400±325.1 17.8±6.1 779.2±506.7 32.7±9.6 608.1±224.1 32.00±5.40 1.1±0.4 




The increasing prevalence of obesity comes with an 
increased risk of infections and cancers that became 
an emerging health concern added to the previously 
established obesity related comorbidities.18,19,20 
Increased risk of infection is linked to the negative 
effect of the nutritional or metabolic disturbances 
on the status of immune cells.21  
In our study we found a higher lymphocytic 
count in obese patients in comparison to non-obese 
ones. This was found in relevant studies by Zaldivar 
et al.22 and Mahassni et al.23, and was explained by 
the increased in plasma levels of cytokines that 
stimulate T-lymphocytes proliferation such as IL-6 
and TNF-alpha, .24,25 Similar to adults, Zaldivaret 
al.22 found elevated CD4 cells in children and was 
explained by an inflammatory process. However, 
the opposite was noted in our series as we found 
that CD4% was low in obese children. This goes in 
accordance with studies done by Tanaka26and 
Amati et al27 who also reported normalization of 
CD4% levels after weight reduction. Elevated 
CD8% found in obese subjects may be explained 
not only by the presence of low systemic 
inflammatory response and high leptin levels, but 
also by increased prevalence of viral infection, high 
levels of oxidative stress, and psychological and 
psychosocial factors such as depression and poor 
quality of life. All of these factors have been shown 
to increase T cell activation and proliferation.28 
The negative correlation between CD4% and 
body weight, BMI, waist hip ratio that we observed 
in the obese group was also noted by Tanaka et al26 
but not by Womack et al32 Tanaka et al26 noted that 
weight reduction can recover the previously 
reduced non CD8 subsets including CD4 T-cells. 
The highly positive correlation between CD8 cell 
(percentage and count) and weight and BMI in the 
obese group matches with data reported by 
Womack et al.32 and O’Rourke et al.33 
NK cells are the first line of defense against 
malignancy and viral infection through detection 
and killing of cancerous and viral-infected cells and 
also by producing cytokines, including IFN-γ, 
which recruit elements of the adaptive immune 
system.34 Obesity is considered an inflammatory 
disease,22,35 however, NK (CD16/CD56) cell 
number did not increase and there was no 
correlation between it and weight or BMI in our 
series. The same was reported by other 
investigators.29-31 On the other hand, Lynch et al,36 
and O’Shea et al34 stated that NK cell number and 
function are altered in obesity and, accordingly, 
obese patients are liable to malignancy and viral 
infection.  
All previous data suggest that obesity can 
potentially affect cell mediated immunity through 
alteration of cell counts and may be also function. 
Seventy five percent of our obese patients gave 
history of recurrent infection enforcing the concept 
of negative effect of obesity on the immune system. 
This was proven by a study conducted in Spain on 
144 patients admitted in intensive care units (ICU). 
It showed that obese patients had higher ICU 
resource consumption and longer length of stay due 
to H1N1 influenza.8,37 Another study by Kim et al38 
revealed that pediatric obesity may have an effect 
on the development of otitis media with effusion. 
In conclusion, obesity seems to reduce 
lymphocyte number causing a variable impairment 
of cell-mediated immune responses. The study is 
indeed limited by the sample size and cross-
sectional design. Further wider scale and 
prospective studies are needed to assess the impact 
of obesity on the function not only the number of 
immune cells which may add predisposition to 
recurrent infection in those children. 
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